Peter J. Weiden, MD
a:1:{i:0;s:79:"Renaissance School of Medicine at Stony Brook University, Stony Brook, New York";}
Original Research
Long-Term Safety of Aripiprazole Lauroxil
August 18, 2020
Long-acting injectable (LAI) antipsychotics improve adherence, reduce treatment gaps, and improve clinical outcomes. This report describes the long-term safety, tolerability, and symptom trajectory with the LAI antipsychotic aripiprazole lauroxil.
